Aspirin

Product NDC: 11673-027
Requested package NDC: 11673-027-12
11-digit product format: 116730027
Labeler code: 11673
Product ID: 11673-027_d8fbf2a5-b155-44db-8683-c99adb4efc5c
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET
Route: ORAL
Labeler: TARGET Corporation
Application: part343
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2013-03-08
Marketing end: 2021-12-31
Substance: ASPIRIN
Active strength: 81 mg/1
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	11673-027	11673-027-12	D	Discontinued by firm		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
11673-027-03	EA - Each	11673-027	bb06130c-11fc-4818-8341-b9557312b809	1	2016-03-04
11673-027-12	EA - Each	11673-027	958477f0-ed20-48e8-8a49-c1d6f2f5d416	1	2017-04-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
BROWN IRON OXIDE	INACTIVE INGREDIENT	1N032N7MFO	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)	INACTIVE INGREDIENT	74G4R6TH13	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
SHELLAC	INACTIVE INGREDIENT	46N107B71O	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
SODIUM BICARBONATE	INACTIVE INGREDIENT	8MDF5V39QO	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	ASPIRIN ENTERIC SAFETY-COATED (ASPIRIN) TABLET [TARGET CORPORATION]	3

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
11673-027-12	11673002712	1 BOTTLE, PLASTIC in 1 BOX (11673-027-12) > 120 TABLET in 1 BOTTLE, PLASTIC	2013-03-08	2021-12-31	No	No	Current